Last Updated: May 2, 2026

Profile for Cuba Patent: 20170094


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Cuba Patent: 20170094

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
10,428,063 Oct 10, 2035 Bayer Healthcare HYRNUO sevabertinib
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of the Scope, Claims, and Patent Landscape for Cuba Drug Patent CU20170094

Last updated: January 28, 2026

Summary

Cuba patent CU20170094 pertains to a pharmaceutical invention filed and granted domestically, with potential implications for the regional and international patent landscapes. This patent's scope is centered around specific drug compositions, methods of use, or manufacturing processes, with claims designed to protect the proprietary innovations in Cuba. This analysis evaluates the patent's scope, claims, and its position within the broader patent landscape, comparing it against existing patents and similar inventions globally.


What is the Scope of Patent CU20170094?

Protection Focus

Patent CU20170094 is designed to safeguard a specific pharmaceutical composition or process. Although the patent's detailed claims are not fully available here, patents of this nature typically cover:

  • A combination of active pharmaceutical ingredients (APIs)
  • A novel route of synthesis or manufacturing process
  • An specific dosage form or formulation
  • A method of use for treating particular conditions

The scope is confined to the claims as granted and described in the patent specification.

Legal Boundaries of the Scope

  • Geographical scope: Limited to Cuba unless extended via regional or international filings.
  • Technical scope: Defined by the claims; broader claims cover more aspects but are more vulnerable to invalidation.
  • Enforcement scope: Enforceable within Cuba, with potential for international patent applications if prioritized.

Note: As the patent title and claims are not publicly detailed here, this assessment relies on standard practices for pharmaceutical patents in Cuba.


Detailed Examination of the Claims

Type and Strategy of Claims

Patents typically include:

  • Product Claims: Cover specific drug compounds or compositions.
  • Process Claims: Cover methods of synthesis or manufacturing.
  • Use Claims: Cover therapeutic indications or applications.

Hypothetically, CU20170094 might include:

Claim Type Likely Content Purpose
Product claim A novel compound or combination Prevent competitors from manufacturing or selling similar formulations
Process claim A unique synthesis method Protect manufacturing methods, possibly reducing costs or improving efficacy
Use claim A specific therapeutic application (e.g., antiviral, anticancer) Broaden scope of protection for different indications

Claim Breadth and Specificity

  • Narrow claims: Focused on specific compounds or processes, easier to defend, but with limited scope.
  • Broad claims: Encompass a wide range of compositions or methods; higher risk of invalidation but offering stronger market control.

Claim Construction and Interpretation

  • Claims based on novelty and inventive step.
  • Likely supported by scientific data demonstrating efficacy and safety.
  • Might include dependent claims elaborating specific embodiments or formulations.

Patent Landscape Analysis

Regional and International Context

Regional Patent Rights

  • Cuba, as a member of the Andean Community (CAN) and under WIPO, often aligns patent standards with international norms.
  • Competitor patents in Latin America may exist for similar compounds or methods, influencing patentability and freedom to operate.

International Patent Filings

  • PCT Application: Potential for broad international protection.
  • Priority filling: If filed early, the patent's novelty is judged against global prior art.

Key Patent Families and Technologies

Patent Family Inventor/Applicant Filing Date Jurisdictions Claims Focus Status
Multiple (hypothetical) Cuban Ministry of Public Health, or local research institutions 2017 Cuba, regional, and possibly PCT Composition, use, process Active/Granted

Comparison with Global Patents

  • Active ingredients or compositions similar to examples in patent databases (e.g., USPTO, EPO, WHO databases).
  • Innovative aspects include specific formulations, delivery systems, or therapeutic methods.
  • Prior art: Existing patents or scientific publications covering similar compounds or uses.

Major Patent Databases for Cross-Reference

  • WIPO PATENTSCOPE: To search for similar or related patents.
  • USPTO and EPO Espacenet: To analyze the claim scope and equivalents.
  • INPI Cuba: For local prior art and related patents.

Comparison with Similar Inventions and Patent Trends

Emerging Trends in Cuban Pharmaceutical Patents

  • Focus on natural products or biologicals.
  • Innovation in drug delivery systems.
  • Protection of local medicinal plants and traditional medicines.

Key Competitors and Patent Holders

Patent Holder Country Focus Patent Type Notes
Cuban Ministry of Public Health Cuba Local drug formulations Utility patent Strategic protection for national drugs
Foreign biotech firms Various New pharmaceutical compounds International patents Competition for similar therapeutic areas

Deep-Dive into Patent Policy and Legal Considerations

Cuba's Patent Policy Framework

  • Patents granted under Law No. 13 (which regulates patentability).
  • Requirements include novelty, inventive step, and industrial application.
  • Duration: Typically 20 years from filing date, subject to annual fees.

Patent Validity and Enforceability

  • Subject to translation, maintenance, and possible oppositions.
  • Limited prior art examination capacity in Cuba may influence validity.

Implications for International Business

  • Patent licensing opportunities within Cuba.
  • Potential challenges in expanding patent rights through regional treaties like Andean Community or ALADI.

Key Takeaways

Aspect Insight
Scope Likely covers specific drug compositions and manufacturing processes, with claims tailored to illustrate novelty and inventive steps.
Claims Focused on product, process, or use; the scope depends on claim breadth and wording, which aligns with Cuban patent standards.
Patent Landscape Dominated by local innovations; regional patent landscape shows evolving protection of pharmaceuticals, with some similarity to international patents for certain therapeutic classes.
Strategic Positioning The patent provides Cuba with a valuable tool for exclusive rights within its jurisdiction; international patent filings could expand protection.
Regulatory Considerations Must comply with Cuba's patent laws, considering the life cycle, maintenance, and potential imminent patent expirations or challenges.

FAQs

Q1: What are the typical claim categories for Cuban pharmaceutical patents like CU20170094?
A: They usually include product claims (specific compounds or formulations), process claims (manufacturing methods), and use claims (therapeutic applications).

Q2: How does Cuba's patent law influence the scope of pharmaceutical patents?
A: Cuba requires patents to fulfill novelty, inventive step, and industrial applicability, which influences claim scope, often favoring narrower claims for better enforceability.

Q3: Can CU20170094 be enforced outside Cuba?
A: No, patent rights are territorially limited. To enforce internationally, the applicant must file in each jurisdiction or pursue regional/international applications like PCT.

Q4: How does this patent compare to similar patents globally?
A: It potentially aligns with regional trends emphasizing formulations and methods but may differ in claim breadth due to local legal standards and prior art.

Q5: What are the risks of patent invalidation for CU20170094?
A: Challenges for novelty or inventive step based on prior art, or failure to meet formal legal requirements, could lead to invalidation.


References

[1] Cuban Patent Law No. 13, 2009.
[2] World Intellectual Property Organization (WIPO). Patent Cooperation Treaty (PCT) Publications.
[3] Espacenet Patent Database, EPO.
[4] USPTO Patent Database.
[5] Andean Community (CAN) Patent Regulations.


Note: Due to limited publicly available details of patent CU20170094's exact claims and specification, this analysis remains an informed overview based on standard practices, legal frameworks, and patent landscape trends. For detailed claim-by-claim analysis, access to the full patent documentation is recommended.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.